Global Biomaterials Market, By Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramics, Natural Biomaterials), Application (Cardiovascular, Orthopaedic, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Neurological/Central Nervous System Applications, Other Applications) – Industry Trends and Forecast to 2030.
Biomaterials Market Analysis and Size
Surging demand for biomaterials in plastic surgery and wound healing applications, rising prevalence of cardiovascular, neurological, and orthopaedic disorders, increasing number of geriatric population across the globe, increasing demand for implantable devices, raised funds and grants by government bodies and universities for the development of novel biomaterials are some of the major as well as essential factors which will likely to augment the growth of the biomaterials market in the projected years.
Data Bridge Market Research analyses that the biomaterials market which was USD 155.05 billion in 2022, would rocket up to USD 441.67 billion by 2030 and is expected to undergo a CAGR of 13.98% during the forecast period. “Polymeric Biomaterials” dominates the type segment of the biomaterials market owing to the wide range of product applications. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Biomaterials Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramics, Natural Biomaterials), Application (Cardiovascular, Orthopaedic, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Neurological/Central Nervous System Applications, Other Applications)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America.
|
|
Market Players Covered
|
Johnson & Johnson. (U.S.), Stryker. (U.S.), CoorsTek Inc.(U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Corbionollagen Matrix, Inc. (U.S.), Carpenter Technology Corporation (U.S.), Berkeley Advanced Biomaterials (U.S.), Covalon Technologies Ltd. (Canada), Medtronic plc (Ireland), BASF SE (Germany), Evonik Industries AG (Germany ), and Invibio Ltd.(U.K.)
|
|
Market Opportunities
|
|
Market Definition
Biomaterial is any substance or combination which may be synthetic or natural in origin. The analysis of biomaterials, which consists of elements such as genetics, medicine, chemistry, and tissue engineering, is known as biomaterials research. These biomaterials are used to communicate with biological processes to treat cardiovascular, dental, orthopaedic, and neurological diseases for medical purposes.
Global Biomaterials Market Dynamics
Drivers
- Increasing prevalence of musculoskeletal and chronic skeletal medical conditions
Musculoskeletal disorders (MSD) are injuries or disorders of the muscles, nerves, tendons, joints, cartilage, and spinal discs. The Department of Labor's Bureau of Labor Statistics defined MSDs as musculoskeletal system and connective tissue diseases and disorders when the exposure or event that caused the condition was repetitive motion, overexertion, or bodily reaction such as bending, climbing, crawling, reaching, or twisting.
According to a recent review of Global Burden of Disease (GBD) 2019 data, 1.71 billion individuals worldwide have musculoskeletal disorders such as rheumatoid arthritis, osteoarthritis, low back pain, neck discomfort, fractures, and other injuries. Such global prevalence of musculoskeletal disease and their increasing cases with most of the population in the majority of countries turning towards older age contribute to new research and development in musculoskeletal disease.
- Rising number of geriatric population
Expanding the geriatric population worldwide is predicted to favour the biomaterial demand as this population is more prone to develop diseases. The number of persons above 65 years is projected to double in the coming years. The old age people are prone to various chronic diseases, such as cardiovascular diseases, endovascular diseases, orthopaedic disorders, and dental disorders, which can foster the demand for the biomaterial across the globe. Kidney implants, joint implants, eye implants, and heart implants are some of the common implantable medical devices among geriatric people.
According to the United Nations, there were around 382 million old age people aged 60 years or above across the globe in 2017, and this number is expected to be 2.1 billion by 2050.
- Increasing demand for implantable devices
Implantable medical devices are devices or tissues which are placed inside or on the surface of the body. Many implants are prosthetics intended to replace missing body parts. Some other implants deliver medication, monitor body functions or support organs and tissues. The implants are placed permanently for diagnostic, monitoring, or therapeutic purposes, or they can also be removed once they are no longer needed. Long-term implants have the advantage of being in a constant-temperature environment. Increasing demand for implantable devices will further act as a driver that will lead to the growth of the biomaterials market in the above-mentioned projected timeframe.
Opportunities
Furthermore, increasing government funds and support for target research activities, rising clinical trials, and growing product innovations and development owing to technological advancements worldwide will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. Additionally, the expansion of money a country uses on its healthcare and its growth rate over time is inclined by a wide variety of economic and social factors, including the financial agreements and structure of the organization of the health system. This will further expand the market's growth rate in the future.
Restraints/Challenges
On the other hand, unfavorable healthcare reforms and stringent clinical and regulatory processes are expected to obstruct market growth. Moreover, the lack of skilled surgeons, along with limitations of biomaterial-based products, is expected to become the most significant and foremost challenge for the development of the market in the forecast period of 2023-2030.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the biomaterials market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
-
In April 2023, Novo Nordisk collaborated with Aspect Biosystems, a company involved in bioprinting biomaterials, for the development of bioprinted tissue therapeutics for obesity and diabetes
-
In November 2019, a Japan-based company, Mitsubishi Chemical signed an agreement with U.S.-based AdvanSource Biomaterials to acquire their thermoplastic polyurethane elastomer business. This acquisition is expected to expand its business footprint globally and capture a significant share of the international market.
Global Biomaterials Market Scope
The market is segmented on the basis of type and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Metallic Biomaterials
- Stainless Steel
- Titanium And Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
- Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Polyvinylchloride
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
- Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
- Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk
Application
- Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
- Orthopaedic
- Joint Replacement
- Knee Replacement
- Hip Replacement
- Shoulder Replacement
- Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Suture Anchors
- Interference Screws
- Meniscal Repair Tacks
- Meshes
- Spine
- Spinal Fusion Surgeries
- Minimally Invasive Fusion Surgeries
- Motion Preservation And Dynamic Stabilization Surgeries
- Pedicle-Based Rod Systems
- Interspinous Spacers
- Artificial Discs
- Fracture Fixation Devices
- Bone Plates
- Screws
- Pins
- Rods
- Wires
- Synthetics Bone Grafts
- Ophthalmology
- Contact Lenses
- Intraocular Lenses
- Functional Replacement Of Ocular Tissues
- Synthetic Corneas
- Others
- Dental
- Dental Implants
- Dental Bone Grafts And Substitutes
- Dental Membranes
- Tissue Regeneration
- Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
- Wound Healing
- Wound Closure Devices
- Sutures
- Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
- Tissue Engineering
- Scaffolds For Regenerative Medicine
- Nanomaterials For Biosensing
- Tailoring Of Inorganic Nanoparticles
- Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds For CNS Repair
- Neural Stem Cell Encapsulation
- Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications
Global Biomaterials Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, type, and application, as referenced above.
The countries covered in this market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America.
North America dominates the biomaterials market due to the prevalence of favourable government policies and the presence of several major market players in this region.
Asia-Pacific is expected to grow at the highest growth rate during the forecast period of 2023 to 2030, owing to strategic initiatives adopted by the regional participants to reinforce their presence in local and global markets.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The biomaterials market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for biomaterials market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the biomaterials market. The data is available for historic period 2010-2021.
Competitive Landscape and Biomaterials Market Share Analysis
The biomaterials market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to biomaterials market.
Some of the major players operating in the biomaterials market are:
- Johnson & Johnson. (U.S.)
- Stryker. (U.S.)
- CoorsTek Inc.(U.S.)
- Zimmer Biomet Holdings, Inc. (U.S.)
- Corbionollagen Matrix, Inc. (U.S.)
- Carpenter Technology Corporation (U.S.)
- Berkeley Advanced Biomaterials (U.S.)
- Covalon Technologies Ltd. (Canada)
- Medtronic plc (Ireland)
- BASF SE (Germany)
- Evonik Industries AG (Germany )
- Invibio Ltd. (U.K.)
SKU-